For the Culture By The Culture. ISSN: 3064-9331.
France keeps extending medical cannabis access while politically resisting broader legalization. Pot Culture Magazine examines the country’s cautious framework, frozen patient access, regulatory delays, and the growing contradiction between public rhetoric and the reality of cannabis reform already unfolding inside France.
The United Kingdom legalized medical cannabis in 2018, but most patients still cannot access it through the NHS. Private clinics filled the gap, creating a two-tier system where legal medicine exists, but access depends on money, specialist approval, narrow guidance, and a regulatory structure now facing sharper scrutiny.
The Netherlands spent decades tolerating cannabis sales while criminalizing the supply chain behind its famous coffeeshops. Now its regulated cultivation experiment is testing whether legal supply can actually replace the legacy market. The result is a European stress test where logistics, hash shortages, inspections, and customer trust matter more than slogans.
Saint Lucia has selected GrowerIQ as its national seed-to-sale traceability backbone, effectively finalizing a digital surveillance grid for its cannabis industry. By mandating enterprise software before establishing licensing frameworks, the government risks automating the exclusion of legacy farmers. This move trades cultural sovereignty for state-managed control, turning the cannabis industry into an extension of the database.
This week’s Reefer Report Card exposes the scromiting panic, Washington’s latest hemp crackdown, and the Supreme Court inching toward a decision that could rewrite prohibition. Patients and veterans stayed stuck in outdated systems while global reform moved forward with hesitation. Panic got headlines. Weed got scapegoated. The world kept smoking anyway.
This week’s Reefer Report Card exposes the hemp industry's battle for survival in the face of a proposed federal THC ban that threatens the entire hemp market. From state-level chaos to Congress playing politics with small farmers and patients, the hemp economy struggles to breathe. No real wins, just industry confusion and political games.